Presentation is loading. Please wait.

Presentation is loading. Please wait.

Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,

Published by은별 섭 Modified over 5 years ago

Similar presentations

Presentation on theme: "Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,"— Presentation transcript:

1 Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee, MD, Myung-Hee Shin, MD, Seonwoo Kim, PhD, Sook Young Woo, MS, Geewon Lee, MD, Joungho Han, MD, Young Mog Shim, MD, Yong Soo Choi, MD  The Annals of Thoracic Surgery  Volume 99, Issue 2, Pages (February 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Patient selection flow sheet. (CT = computed tomography.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Various computed tomography (CT) stages of thymic epithelial tumors. (A) Stage I, well encapsulated thymic epithelial tumor (arrow) of World Health Organization (WHO) classification A and Masaoka-Koga stage I in a 37-year-old woman. (B) Stage II, tumor invasion into surrounding mediastinal fat (arrow) of WHO classification AB and Masaoka-Koga stage II in a 66-year-old man. (C) Stage III, tumor invasion into superior vena cava (arrow) of WHO classification B3 and Masaoka-Koga stage III in a 60-year-old man. (D) Stage IV, tumor pleural seeding (arrow) of thymic carcinoma (star) and Masaoka-Koga stage IV in a 34-year-old woman. (E) Stage IV, bilateral hilar and subcarinal lymph node metastases (arrows) of thymic carcinoma (star) and Masaoka-Koga stage IV in a 30-year-old man. (F) Stage IV, pulmonary metastases (arrow) of thymic carcinoma (star) and Masaoka-Koga stage IV in a 49-year-old man. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival (OS) and progression-free survival (PFS) curves. Regarding (A) OS curves and (B) PFS curves according to Masaoka-Koga staging, no significant difference is shown between stage I (black lines) and stage II (red lines), whereas significant drops in survival are noted between stage III (green lines) and stage IV (blue lines) in OS. Significant difference in PFS is also noted between stages III and IV. On (C) OS curves and (D) PFS curves according to simplified WHO classification, significant difference in survival among WHO classifications A, AB, and B1 (black lines), B2 and B3 (red lines), and carcinoma (green lines) is shown. Both (E) OS curves and (F) PFS curves according to completeness of resection (R0) show that R2 (green lines) renders significantly poorer OS and PFS as compared with R0 (black lines) and R1 (red lines). However, difference in prognosis between R0 and R1 is not significant. The (G) OS curves and (H) PFS curves according to computed tomography (CT) stages I (black lines), II (red lines), III (green lines), and IV (blue lines) demonstrate that significant drops in both OS and PFS are seen between various combinations of all CT stages. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 3 Overall survival (OS) and progression-free survival (PFS) curves. Regarding (A) OS curves and (B) PFS curves according to Masaoka-Koga staging, no significant difference is shown between stage I (black lines) and stage II (red lines), whereas significant drops in survival are noted between stage III (green lines) and stage IV (blue lines) in OS. Significant difference in PFS is also noted between stages III and IV. On (C) OS curves and (D) PFS curves according to simplified WHO classification, significant difference in survival among WHO classifications A, AB, and B1 (black lines), B2 and B3 (red lines), and carcinoma (green lines) is shown. Both (E) OS curves and (F) PFS curves according to completeness of resection (R0) show that R2 (green lines) renders significantly poorer OS and PFS as compared with R0 (black lines) and R1 (red lines). However, difference in prognosis between R0 and R1 is not significant. The (G) OS curves and (H) PFS curves according to computed tomography (CT) stages I (black lines), II (red lines), III (green lines), and IV (blue lines) demonstrate that significant drops in both OS and PFS are seen between various combinations of all CT stages. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Thymic Epithelial Tumors: Prognostic Determinants Among Clinical, Histopathologic, and Computed Tomography Findings  Jung Won Moon, MD, Kyung Soo Lee,"

Similar presentations

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 

Ricardo L. Oliveira, MD, Moishe Liberman, MD, PhD 
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.

FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis  Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates  Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.

Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates  Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.
Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations  Tae Jung Kim, MD, PhD, Choon-Taek.

Radiologic Characteristics of Surgically Resected Non-Small Cell Lung Cancer With ALK Rearrangement or EGFR Mutations  Tae Jung Kim, MD, PhD, Choon-Taek.
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Novel Approach to Recurrent Cavoatrial Renal Cell Carcinoma

Novel Approach to Recurrent Cavoatrial Renal Cell Carcinoma
Clinical Characteristics and Prognostic Factors of Primary Pulmonary Vein Stenosis or Atresia in Children  Mi Kyoung Song, MD, Eun Jung Bae, MD, Soo In.

Clinical Characteristics and Prognostic Factors of Primary Pulmonary Vein Stenosis or Atresia in Children  Mi Kyoung Song, MD, Eun Jung Bae, MD, Soo In.
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Equivalency of Saphenous Vein and Arterial Composite Grafts: 5-Year Angiography and Midterm Clinical Follow-Up  Ho Young Hwang, MD, PhD, Kyung-Hak Lee,

Equivalency of Saphenous Vein and Arterial Composite Grafts: 5-Year Angiography and Midterm Clinical Follow-Up  Ho Young Hwang, MD, PhD, Kyung-Hak Lee,
Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical Course  Sook Hwan Sung, MD, Jee-Won Chang, MD, Jhingook Kim, MD, Kyung Soo Lee, MD,

Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical Course  Sook Hwan Sung, MD, Jee-Won Chang, MD, Jhingook Kim, MD, Kyung Soo Lee, MD,
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Andranik Petrosyan, MD, Patrice Bergeron, MD 

Andranik Petrosyan, MD, Patrice Bergeron, MD 
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Similar presentations

Ads by Google